Related Experiment Videos
Resistant hypertension: diagnosis and management.
Annals of Internal Medicine
|May 1, 1978
Summary
Resistant hypertension is uncommon, often due to non-adherence or secondary causes. Identifying underlying mechanisms and new drugs like minoxidil can improve treatment for difficult hypertension cases.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Resistant hypertension, failing to respond to standard drug regimens, is rare.
- Common reasons for apparent treatment failure include poor patient compliance, excessive salt intake, drug interactions, inaccurate readings, or secondary hypertension.
- Understanding the mechanisms of resistance is key to effective management.
Purpose of the Study:
- To review the causes of hypertension resistant to medical treatment.
- To discuss strategies for managing resistant hypertension by identifying underlying mechanisms.
- To introduce potential new pharmacologic agents for resistant hypertension.
Main Methods:
- Literature review of causes and management of resistant hypertension.
- Discussion of hemodynamic and humoral factors contributing to resistance.
- Overview of investigational drugs targeting total peripheral resistance.
Main Results:
- Most cases of apparent resistant hypertension have identifiable causes other than true drug resistance.
- Tailoring treatment based on specific hemodynamic and humoral profiles can improve outcomes.
- Newer agents like minoxidil and oral converting enzyme inhibitors show promise.
Conclusions:
- True resistant hypertension is rare, with most cases attributable to secondary factors or non-compliance.
- Personalized therapeutic approaches targeting specific resistance mechanisms are crucial.
- Emerging pharmacotherapies offer new hope for managing refractory hypertension.